Browsing by Subject "Glomerulonephritis"

Sort by: Order: Results:

Now showing items 1-4 of 4
  • Kaartinen, Kati; Martola, Leena; Aaltonen, Sari (2019)
    Glomerulonefriitti on yleisnimitys taudeille, jotka vaurioittavat munuaiskeräsiä immunologisella mekanismilla. Myös geneettiset ja ympäristötekijät ovat vaikuttamassa. Se voi löytyä oireettomana sattumalöydöksenä tai osana yleisoireista tautia. Diagnoosi perustuu munuaiskoepalaan, eikä eri glomerulonefriittejä voida varmuudella erotella toisistaan kliinisin perustein. Yhteistä kaikkien glomerulonefriittien hoidolle ovat verenpaineen ja proteinurian hoito. Osa tarvitsee myös immunomoduloivaa hoito
  • Helanterä, Ilkka; Peltonen, Reetta (2019)
  • Mustonen, Jukka; Vaheri, Antti; Pörsti, Ilkka; Mäkelä, Satu (2022)
    • Myyräkuumeen akuuttiin vaiheeseen liittyy joskus vaikeita komplikaatioita. • Vaikeat pitkäaikaisseuraukset ovat harvinaisia. • Useita viikkoja kestävä väsymys on tavallista. • Jos potilas ei toivu taudistaan, on syytä sulkea pois hormonitoiminnan häiriöt.
  • Koskela, Mikael; Ylinen, Elisa; Ukonmaanaho, Elli-Maija; Autio-Harmainen, Helena; Heikkilä, Päivi; Lohi, Jouko; Jauhola, Outi; Ronkainen, Jaana; Jahnukainen, Timo; Nuutinen, Matti (2017)
    Histological findings from primary kidney biopsies were correlated with patient outcomes in a national cohort of paediatric Henoch-Schonlein nephritis (HSN) patients. Primary kidney biopsies from 53 HSN patients were re-evaluated using the ISKDC (International Study of Kidney Disease in Children) classification and a modified semiquantitative classification (SQC) that scores renal findings and also takes into account activity, chronicity and tubulointerstitial indices. The ISKDC and SQC classifications were evaluated comparatively in four outcome groups: no signs of renal disease (outcome A, n = 27), minor urinary abnormalities (outcome B, n = 18), active renal disease (outcome C, n = 3) and renal insufficiency, end-stage renal disease or succumbed due to HSN (outcome D, n = 5). For the receiver operating characteristic and logistic regression analyses, outcomes A and B were considered to be favourable and outcomes C and D to be unfavourable. The median follow-up time was 7.3 years. The patients with an unfavourable outcome (C and D), considered together due to low patient numbers, had significantly higher total biopsy SQC scores and activity indices than those who had a favourable one (groups A and B). The chronicity and tubulointerstitial indices differed significantly only between group C + D and group A. The difference in areas under the curve between the total biopsy SQC scores and ISKDC findings was 0.15 [p = 0.04, normal-based 95% confidence interval (CI) 0.007-0.29, bias-controlled 95% CI -0.004 to 0.28]. Our results suggest that the modified SQC is more sensitive than ISKDC classification for predicting the outcome in HSN cases.